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Abstract
Objective: Beta cells of pancreatic islets are susceptible to functional deficits and damage by hypoxia. Here we aimed to
characterize such effects and to test for and pharmacological means to alleviate a negative impact of hypoxia.
Methods and Design: Rat and human pancreatic islets were subjected to 5.5 h of hypoxia after which functional and
viability parameters were measured subsequent to the hypoxic period and/or following a 22 h re-oxygenation period.
Preconditioning with diazoxide or other agents was usually done during a 22 h period prior to hypoxia.
Results: Insulin contents decreased by 23% after 5.5 h of hypoxia and by 61% after a re-oxygenation period.
Preconditioning with diazoxide time-dependently alleviated these hypoxia effects in rat and human islets. Hypoxia reduced
proinsulin biosynthesis (3H-leucine incorporation into proinsulin) by 35%. Preconditioning counteracted this decrease by
91%. Preconditioning reduced hypoxia-induced necrosis by 40%, attenuated lowering of proteins of mitochondrial
complexes I–IV and enhanced stimulation of HIF-1-alpha and phosphorylated AMPK proteins. Preconditioning by diazoxide
was abolished by co-exposure to tolbutamide or elevated potassium (i.e. conditions which increase Ca2+ inflow).
Preconditioning with nifedipine, a calcium channel blocker, partly reproduced effects of diazoxide. Both diazoxide and
nifedipine moderately reduced basal glucose oxidation whereas glucose-induced oxygen consumption (tested with
diazoxide) was unaffected. Preconditioning with diaxoxide enhanced insulin contents in transplants of rat islets to non-
diabetic rats and lowered hyperglycemia vs. non-preconditioned islets in streptozotocin-diabetic rats. Preconditioning of
human islet transplants lowered hyperglycemia in streptozotocin-diabetic nude mice.
Conclusions: 1) Prior blocking of Ca2+ inflow associates with lesser hypoxia-induced damage, 2) preconditioning affects
basal mitochondrial metabolism and accelerates activation of hypoxia-reactive and potentially protective factors, 3) results
indicate that preconditioning by K+-ATP-channel openers has therapeutic potential for islet transplantations.
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Introduction
Pancreatic beta cells display a high degree of oxidative
metabolism. This makes their function and survival very sensitive
to hypoxia and even mild hypoxia is known to inhibit insulin
release [1]. From a clinical perspective hypoxia in beta cells is of
great concern, since it is a major factor behind the demise of beta
cells following transplantation [2,3,4]. Elucidating the possibilities
and requirements for hypoxia-adaptive processes in beta cells are
bound to be important for on-going efforts to improve the so far
limited success [5] of islet transplantation in diabetic patients.
The effects of hypoxia on beta cells and ways to minimize
hypoxia-induced damage are only partly elucidated. Adaptation to
- relative - hypoxia can be demonstrated in most tissues and
constitutes a basic survival mechanism [6]. However, the
conditions that are best suited for beta cell adaptation to hypoxia
are poorly defined and the possibilities to enhance adaptation by
pharmacological means are largely unexplored.
In the present study we first investigated the impact of a
standardized exposure to hypoxia on beta cells. Parameters of
function and survival were assessed before and after a period of re-
oxygenation. We then tested for conditions prior to hypoxia (i.e.
preconditioning) that could be protective against the negative
impact of hypoxia. The K+-ATP-channel opener diazoxide has
been shown to be protective in heart and nervous tissue [7]: it was
therefore chosen for testing. Upon finding beneficial effects we
PLOS ONE | www.plosone.org 1 July 2013 | Volume 8 | Issue 7 | e67498
proceeded to test for mechanisms as well as effects in transplan-
tation settings.
Materials and Methods
Materials
Ultrapure sodium alginate, Pronova UP-LVG (.60% guluronic
acid, viscosity 20–200 mPa?s, endotoxin ,100 EU/g) was from
Nova Matrix (Oslo, Norway). All other chemicals were from
Sigma, St Louis MO.
Methods
Ethics. All animal studies were approved by the Northern
Stockholm Ethical Committee on Experimental Animal Care
(236/08; 388/10; 335/11; 100/11; 88/11; 28/08) and performed
in accordance with guidelines from the Swedish National Board
for Laboratory Animals. The protocol used in Trondheim was
approved by the Norwegian Animal Research Authority (Permit
Number FOTS 3114). Human islets used in Stockholm were
obtained from a Nordic network under conditions specified
elsewhere [8]. Human islets used in Trondheim were isolated at
the Division of Transplant, University of Illinois (Chicago), and
shipped to Norway. The protocol used in Trondheim was
approved by the regional ethical committee in Norway (2011/
782).
Animals. Male Sprague-Dawley rats were from Scanbur
(Sollentuna, Sweden) and male NMRI nu/nu mice were obtained
from Taconic (Denmark). Animals were maintained in a 12-h
(0600–1800 h) light/dark cycle with free access to water and a
standard diet. The rats weighed 250–350 g and the mice 35.5–
49.3 g (33 weeks old) at the time of experiments.
Isolation, culture, and incubation of rat pancreatic
islets. Islets of Langerhans were isolated by collagenase
digestion (Roche Diagnostics) followed by sedimentation. The
general design of the experiments is depicted in Fig. 1. Islets were
selected under a stereomicroscope. Care was taken to select only
medium sized islets. Islets were transferred to 5 ml Petri dishes
(Sterilin, Teddington, U.K.) containing RPMI-1640, 2 mmol/l
glutamine, 10% (vol/vol) FCS, 100 units/ml benzylpenicillin,
0.1 mg/ml streptomycin, and 11 mmol/l glucose, each with or
without the co-presence of 325 mmol/l diazoxide and/or other test
substances as specified by each protocol. After this initial period of
culture ( = preconditioning period) the medium was changed to
RPMI with 11 mmol/l glucose. Islets were then cultured free-
floating for 5.5 h, usually at 37uC, either during continued
normoxia in an atmosphere of 5% CO2 in air or during hypoxia
( = hypoxia period). Hypoxia was achieved by a hypoxia chamber
(Billup-Rothenberg, Calif). It was equilibrated with a gas mixture
of 95% nitrogen and 5% CO2, achieving a stable reduction of
oxygen to 0.8% during the standard experimental set-up. Islets,
whether exposed to hypoxia or not, were then transferred to new
dishes with the same composition of RPMI and cultured for
another 22 h during normal (i.e. normoxic) conditions ( = re-
oxygenation period).
Human islets incl. microencapsulation. Pancreata were
obtained from normoglycemic cadaveric donors after appropriate
consent for multiorgan donation. Islets were cultured for 48 h in
5.5 mmol/l glucose before experiments.
Microencapsulation was performed basically as described by
Strand et al [9]. Capsule diameters (mean 6 SEM, n = 33) were
measured to 521610 mmeter. After 4 days of culture, two
suspensions of microencapsulated islets (3600 IEQ each) were
incubated in culture media supplemented with either diazoxide (to
a final concentration of 325 mmol/l) or an equal volume of
0.1 mol/l NaOH (control islets) for 48 h. Aliquots containing 600
IEQ each were collected for transplantation.
Transplantations. Three types of experiments were per-
formed.
1. Non-diabetic rats: After culture for 22 h with or without
325 mmol/l diazoxide in vitro 50–150 islets were transplanted
under the left kidney capsule as described [10]. Five days later
the recipient rats were sacrificed and the transplants cut out
and processed as described below.
2. Streptozotocin-diabetic rats: Equal weight male Sprague-
Dawley rats were injected intraperitoneally (i.p.) with strepto-
zotocin. Rats with blood glucose level consistently above
16 mmol/l were used as recipients. Islets from non-diabetic
rats were cultured overnight with 11 mmol/l glucose with or
without 325 mmol/l diazoxide or 10 mmol/l of nifedipine.
Equal amount of islets (1200–1600 islets for each rat) were
transplanted i.p. Levels of blood glucose were measured by
AccuCheck Aviva (Roche Diagnostics).
3. Streptocotozin-diabetic nude mice: Diabetes was induced by
i.p. injection of 150 mg/kg of streptozotocin. All mice that
were used for experiments had blood glucose levels above
19 mmol/l 3 days after streptozotocin. For transplantations
equal weight male NMRI nu/nu mice were anaesthetized with
isofluran. A 0.3 cm abdominal incision was made to infuse
encapsulated (48 h preculture 6325 mmol/l diazoxide) human
Figure 1. General study design. Islets were cultured in
11 mmol/l glucose throughout with and without diazoxide
and other additions (see text) for 22 h ( =preconditioning).
Islets were then exposed to hypoxia for 5.5 h ( = hypoxia). After hypoxia
culture was continued in normoxia for 22 h ( = re-oxygenation).
Constant normoxia was used as control. The re-oxygenation period
was in most, but not in all, experiments followed by final incubations
which included preincubation (30 min) followed by a glucose challenge
(60 min).
doi:10.1371/journal.pone.0067498.g001
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islets (600 IEQ) i.p. Blood glucose and weight were measured
every day during a 14 day period post transplantation.
Immunoreactive insulin. Immunoreactive insulin (IRI) was
measured by RIA [11]. Cross-reactivity with human proinsulin
was about 80%. Isolated islets and transplants were extracted for
IRI in acid-ethanol [12].
Degradation of insulin. A pulse-chase method was em-
ployed, basically as described [13].
Proinsulin. Proinsulin was measured by the Rat/Mouse
proinsulin ELISA kit (Mercordia, Uppsala, Sweden) according to
the manufacturer’s instructions. According to the manufacturer,
this assay is specific for rat and mouse proinsulin I and II.
Western blotting. The procedure is described in [14]. For
mitochondrial proteins we refrained from boiling the samples.
Samples containing 30 (mitochondrial complexes I, II and IV) and
10 (complexes III and V, and beta actin) mg protein were
prepared. Primary antibodies were used at the following dilutions:
1:2,000 for HIF-1a (Novus Biologicals, Inc. USA), 1:2,000 for
AMPKa and phosphorylated AMPKa (Cell Signaling Technolo-
gy, MA, USA), 1:20,000 for beta-actin (Sigma) and 1:500 for
oxidative phosphorylation complexes 1–5 MS604 (MitoSciences,
Eugene, OR, USA).
Protein biosynthesis. We measured the incorporation of
[3H]-leucine into proinsulin and total islet proteins [15].
Glucose oxidation. Production of 14CO2 from D-[U-
14C]
glucose was measured basically as described [16].
Oxygen consumption rate (OCR). This was measured
employing Sea-Horse technology basically as described [17].
Seventy equally sized islets were used for each well.
ATP and ADP. An ATP Bioluminescence Assay Kit HS II
(Roche) was used. ADP was measured after enzymatic elimination
of ATP (to AMP) followed by conversion of ADP to ATP as
described [18].
Total DNA, mitochondriaDNA/nuclearDNA and
protein. Total DNA was measured by a fluorescent DNA
Quantitation Kit (Bio-Rad) and protein content by the DC Protein
Assay Kit (Bio-Rad).
For mitochondrial (mt)DNA islet DNA was extracted by
DNeasy Blood and Tissue kit (Qiagen, Sweden). Mitochondrial
relative DNA copy number was determined by calculation of the
mtDNA/nuclear (n) DNA to the control ratio (11 mmol/l glucose
without hypoxia) [19]. mtDNA-encoded NADH dehydrogenase 2
gene (ND-2) served as marker for total mtDNA and 18S rDNA for
nDNA. Primers and real-time PCR kit were from Applied
Biosystems.
Necrosis and apoptosis. The Cell Death Detection ELI-
SAPLUS kit (Roche Diagnostics) was used. Samples were placed
into streptavidin-coated microplates and incubated with a mixture
of anti-histone-biotin and anti-DNA-peroxidase. Islet culture
media were analyzed for necrosis and islet lysates for apoptosis.
Statistical analysis. Results are expressed as mean 6 SEM.
Significant differences were tested using Student’s paired t test
(two-sided) or, for multiple comparisons, one way ANOVA. The
Student-Newman-Keuls method was used for post-hoc analysis. A
P value,0.05 was considered significant.
Results
Hypoxia induces lasting effects on IRI secretion and
cellular contents
A 5.5 h period of hypoxia (design of experiments depicted in
Fig. 1) almost abolished the accumulation of IRI into the culture
medium (Fig. 2). The IRI response to 16.7 mmol/l glucose was
markedly reduced when tested in sequence to the hypoxic event,
(Fig. 3A). The response was partly normalized after re-oxygenation
but still diminished (to 28% of the response of islets cultured
during continuous normoxia, Fig. 3A). Islet contents of IRI were
reduced after the period of hypoxia (Fig. 3B) and further reduced
following the period of re-oxygenation (from 1044677 to
409644 mU/islet, Fig. 3B).
We tested the possibility of hypoxia accelerating the degradation
of cellular insulin. Islets were labelled with [4,5-3H] leucine for
48 h and then pulse-chased. Duplicate measurements of insulin-
antibody-precipitated radioactivity showed no decrease due to
5.5 h of hypoxia whether tested immediately after hypoxia or after
the re-oxygenation period (results not shown).
During a lesser degree of hypoxia, i.e. exposure to 2.7–3.0% of
oxygen the release of insulin into the culture medium was reduced
by 83%. This inhibition was similar to that achieved by 0.8% of
oxygen. Previous hypoxia slightly increased basal secretion in
batch type incubations performed after re-oxygenation (p,0.04).
Glucose-induced insulin secretion was however not altered (mean -
5.364.3%). In contrast, insulin contents were clearly reduced by
the lesser degree of hypoxia (from 8406173 to 5736114 mU/islet,
P = 0.002, n = 4).
Pre-exposure to diazoxide protects against hypoxia-
induced reduction of insulin contents
The 22 h period of pre-exposure to diazoxide modestly
improved a glucose-induced insulin response as measured after
the re-oxygenation period (Fig. 3A). The effect by preconditioning
on islet insulin contents was much more profound. Insulin contents
were 2.7 fold increased relative to hypoxia-exposed islets, which
had not been pre-treated for 22 h with diazoxide (Fig. 3C,
compare left and right columns). The effect of diazoxide on insulin
contents was not paralleled by diminished secretion during the re-
oxygenation period (Fig. 2).
A 2 h pre-exposure to diazoxide exerted only a minor effect on
islet insulin contents following re-oxygenation (Fig. 3C, middle
column). No effect was seen when a 2 h exposure to diazoxide was
followed by 22 h of normoxia before hypoxia (284 vs. 283 mU/
islet without previous diazoxide, mean of two experiments). When
diazoxide was present during the 5.5 h period of hypoxia - but not
present before hypoxia - we found only a tendency for a minor
Figure 2. Effects of hypoxia on insulin accumulation in culture
media. Shown are effects during preconditioning (22 h6diazoxide),
5.5 h of normoxia/hypoxia (6 previous diazoxide) and subsequently
22 h of re-oxygenation (previous normoxia/hypoxia 6 previous
diazoxide). Mean 6 SEM of four experiments. Red columns: normox-
ia;blue columns: hypoxia.
doi:10.1371/journal.pone.0067498.g002
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increase in IRI insulin contents after re-oxygenation (increase
+2166%, P = 0.086, n = 4).
Pre-exposure to diazoxide did not affect glucose-induced insulin
secretion when employing the lesser degree of hypoxia, i.e.
exposure to 2.7–3.0% of oxygen However, diazoxide partly (by
59%) prevented the hypoxia-induced reduction in insulin contents,
P = 0.01 vs. no previous diazoxide, n = 4.
Effects on proinsulin
The 5.5 h period of hypoxia markedly reduced islet proinsulin
contents (Fig. S1A). The decrease was similar in pre-conditioned
and in non-preconditioned islets, 8564% and 6667% respective-
ly. Re-oxygenation increased proinsulin contents by 168658%,
P,0.01 in pre-conditioned and non-significantly by 55640% in
non-preconditioned islets. Ratios of proinsulin to IRI after re-
oxygenation were lower in pre-conditioned vs. non pre-condi-
tioned islets (Fig. S1B).
Reduced insulin biosynthesis is a sequel of hypoxia and is
partially reversed by diazoxide
Islets that had experienced hypoxia displayed diminished
proinsulin biosynthesis (by 3566%), after the re-oxygenation
period (Fig. 4A). Total protein biosynthesis appeared to be
depressed to a lesser extent (by 2166%, Fig. 4B). Importantly, the
decrease in proinsulin biosynthesis was partially and significantly
reversed by preconditioning with diazoxide (Fig. 4A).
Preconditioning reduces hypoxia-induced cell death
Necrosis was not observed when measured immediately after
hypoxia but was apparent after re-oxygenation (Figs. 4C+D)
Apoptosis was increased 2.360.4 fold, n = 4, P,0.05). Precondi-
tioning reduced cell necrosis by 40%, (Fig. 4D) but did not affect
an elevated rate of apoptosis (results not shown).
Mitochondrial effects
Effects on insulin biosynthesis could be related to perturbations
in energy production. We therefore tested for hypoxia-induced
mitochondrial dysfunctions and modulation by diazoxide. Hyp-
oxia severely reduced proteins of mitochondrial complexes I–V
(Fig. 5). After re-oxygenation complexes II, III, IV and V were
instead up-regulated whereas a decrease in complex I persisted.
The effects of hypoxia before and after re-oxygenation were, in
general, dampened by previous diazoxide. Importantly, precon-
ditioning with diazoxide lessened the decrease of complex I after
hypoxia as well as after re-oxygenation (Fig. 5).
Previous hypoxia decreased basal oxygen consumption (by
5366%, n = 10, Fig. 6 A, B, C). The relative increase in response
Figure 3. Effects of hypoxia and diazoxide on insulin secretion and islet insulin content. Shown are in A immediate effects (left part of
figure) by 5.5 h of hypoxia on secretion and late effects, i.e. after re-oxygenation (right part of figure) including preconditioning with diazoxide (Dz).
Glucose-induced insulin secretion was assessed in incubations with 3.3 and 16.7 mmol/l glucose. B and C depict islet insulin content. Mean6 SEM of
seven experiments. In A: *P,0.02 vs. normoxia; {P,0.01 vs. no re-oxygenation; `P,0.02 vs. normoxia after re-oxygenation. In B: *P,0.02 vs.
uninterrupted normoxia. In A: 1P=0.027 vs. no previous diazoxide. In C: *P,0.001 for an effect of 22 h and {P,0.01 for an effect of 2 h of previous
diazoxide. Red columns: normoxia; blue columns: hypoxia.
doi:10.1371/journal.pone.0067498.g003
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to glucose was however not negatively affected. Preconditioning
with diazoxide did not alter the effects by hypoxia on oxygen
consumption in response to glucose. Addition of oligomycin and
FCCP qualitatively produced expected effects both with and
without previous hypoxia, however the inhibitory effect of
oligomycin did not level off even after 45–60 min exposures (data
not shown), thus precluding calculations of coupled vs. uncoupled
respiration. The ratio mtDNA/nDNA was decreased by hypoxia
and was also slightly decreased by diazoxide both before and after
hypoxia (Table 1). Levels of ATP and ADP were decreased even
when taking into account a hypoxia-induced decrease of total
DNA (Table 1). Preconditioning did not affect these parameters.
Hypoxia markedly depressed glucose oxidation, both when
measured closely in time after the exposure and after re-
oxygenation (Fig. 6D). Regulation by glucose was preserved (data
not shown). Preconditioning with diazoxide was associated with a
moderate reduction of oxidation, when measured before hypoxia
(Fig. 6D). No effect vs. hypoxia alone was evident when measured
sequentially after hypoxia. However, basal oxidation was more
depressed when measured after re-oxygenation than after hypoxia
alone. On the other hand the glucose-induced increase in
oxidation was unaltered (data not shown).
Considering our results on glucose oxidation we tested the
possibility that a reduction of ATP synthesis prior to hypoxia could
exert a protective effect. However, a 22 h preconditioning period
with 2 nmol/l oligomycin, which inhibits ATP synthesis, did not
induce preconditioning (insulin content being 428661 vs.
285627 mU/islet with oligomycin present during the precondi-
tioning period, n = 4). (For optimizing the oligomycin concentra-
tion we performed dose-response experiments testing 2, 20 and
200 nmol/l in culture of rat islets together with 11 mmol/l glucose
over night. Glucose induced insulin secretion in batch incubations
the following day showed that secretion was inhibited by
approximately 50% already at the lowest concentration of
oligomycin and that higher concentrations resulted in almost
complete inhibition and elevated basal levels indicating general-
ized toxicity).
The preconditioning effect does not depend on de novo
protein synthesis
The requirement for long term exposure to diazoxide for
hypoxia-protective effects could indicate dependence on protein
synthesis. However, co-exposure to the protein synthesis inhibitor
cycloheximide (10 mmol/l) during 22 h of preconditioning did not
affect preconditioning (data not shown).
The preconditioning effect of diazoxide is abolished by
co-culture with tolbutamide and elevated potassium and
partly mimicked by nifedipine
Tolbutamide closes K+-ATP dependent channels, thus exerting
the opposite effect of diazoxide on these channels. It was therefore
Figure 4. Effect of hypoxia and preconditioning with diazoxide (22 h) on biosynthesis and necrosis. A depicts insulin biosynthesis and
B: total protein biosynthesis. Mean6 SEM of six experiments in A and B. In A: *P=0.01 vs. normoxia, {P,0.03 vs. no previous diazoxide. In B: *P= 0.01
vs. normoxia. C depicts effect of preconditioning with diazoxide on necrosis measured in cell culture supernatants directly after hypoxia and D when
measured after re-oxygenation. Mean 6 SEM of four experiments in C and D. In D: *P,0.05 vs. normoxia, {P,0.05 vs. no previous diazoxide. Red
columns: normoxia; blue columns: hypoxia.
doi:10.1371/journal.pone.0067498.g004
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Figure 5. Effects of hypoxia on mitochondrial complexes I–V and modifying influences of preconditioning. Immunoblotting (for details
see Methods) of sub-units of the complexes were performed on islets that were harvested after hypoxia or after 22 h of re-oxygenation. Typical
Western blots from one experiment are shown in the upper part of the figure. Line charts show mean 6 SEM of five (after hypoxia) or six (after re-
oxygenation) individual experiments and are expressed as percentage of results in islets constantly cultured at normoxia. *P,0.05 or less vs. no
previous diazoxide. 11G= 11 mmol/l glucose; hy =hypoxia, hydz =hypoxia+diazoxide.
doi:10.1371/journal.pone.0067498.g005
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of interest to determine whether co-culture with tolbutamide
influenced preconditioning. The concentration of tolbutamide
(100 mmol/l) was chosen to abolish the inhibitory effect by
diazoxide on glucose-induced insulin secretion during the precon-
ditioning period (mean of n = 4, Fig. 7A). Tolbutamide totally
abolished preconditioning by diazoxide on cellular insulin contents
(Fig. 7B).
Tolbutamide could exert its effects by a primary action on K+-
ATP-channels or by a secondary effect on Ca2+ inflow through
voltage-dependent calcium channels. These alternatives were
Figure 6. Oxygen consumption rates (A–C) and glucose oxidation (D and E). Oxygen consumption was measured after the re-
oxygenation period by a ‘‘Sea Horse’’ instrument (A–C). In A, mean and SEM are shown from islets of four rats which were - separately for
each rat - placed in parallel wells and processed in the same experiment. B presents a summary of basal and glucose-stimulated oxygen consumption
from ten experiments, measured at basal (3.3 mmol/l) and glucose stimulated (16.7 mmol/l) respiration. In C, values from (B) were normalized to
basal O2 consumption (11 mmol/l glucose). *P,0.05 or less vs. no previous hypoxia. D and E depict effects on glucose oxidation by preconditioning
with diazoxide (D) or nifedipine (E). Glucose oxidation was measured at 11 mmol/l glucose closely before and after hypoxia as well as after re-
oxygenation. Mean 6 SEM of six experiments in D and E: *P,0.05 for effect of previous diazoxide or nifedipine.
doi:10.1371/journal.pone.0067498.g006
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tested by adding 30 mmol/l potassium during the preconditioning
period. Elevated concentrations of potassium would per se
depolarize the cell membrane, thereby short-circuiting any
influence of K+- ATP channels. Elevated potassium reversed the
inhibitory effect of diazoxide during the preconditioning period
(n = 4, Fig. 7A) and reversed the preconditioning effect on islet
insulin content (Fig. 7B).
To further document an association between inhibition of Ca2+
inflow and preconditioning we tested for effects by nifedipine
which blocks Ca2+ inflow through L-type calcium channels.
Preconditioning for 22 h with nifedipine (10 mmol/l) inhibited
glucose-induced accumulation of insulin into the culture medium
to a degree similar to that of diazoxide (Fig. 7A). Preconditioning
with nifedipine protected against the hypoxia-induced decrease in
islet IRI contents (Fig. 7B), again an effect similar to that of
diazoxide (but somewhat less marked). Glucose-induced insulin
secretion was only marginally improved (results not shown).
Further, in analogy with diazoxide, nifedipine inhibited glucose
oxidation to a moderate extent (Fig. 6E).
Cooling-induced inhibition of exocytosis fails to exert
protective effects
Cooling inhibits exocytosis much more severely than Ca2+inflow
[20,21,22]. We employed cooling to separate effects on Ca2+
inflow from attendant effects on insulin secretion. The effects of
cooling to 28 degrees were tested during the standard precondi-
tioning period of 22 h at the standard glucose concentration of
11 mmol/l. Cooling markedly inhibited insulin secretion (by
6462%) under these conditions (Fig. 7A). Such inhibition did not
however, protect against the negative effects of hypoxia on insulin
contents (Fig. 7B) or on glucose-induced insulin secretion (at 37
degrees, results not shown).
Diazoxide enhances the induction of hypoxia inducible
factor 1 alpha (HIF- 1 alpha) and AMPK
HIF-1-alpha and AMPK are recognized as universal factors in
the adaptation to hypoxia (reviews [6,23]). The levels of HIF-1-
alpha protein were dramatically increased immediately after
hypoxia from a baseline of a small but detectable signal during
normoxia (Fig. 7C). Effects of diazoxide on HIF-1 alpha protein
were complex. During normoxia the presence of the drug tended
to decrease the HIF-1 alpha signal. The signal was however
actually enhanced following 5.5 h of withdrawal of the drug (i.e.
during continued normoxia). Immediately after 5.5 h of hypoxia
the HIF-1 alpha protein was, as mentioned, markedly increased,
but this increase was further enhanced by preconditioning with
diazoxide (Fig. 7C).
Hypoxia markedly activated the phosphorylated form of
AMPK, the ratio of phosphorylated to non-phosphorylated form
increasing both immediately after hypoxia and after re-oxygena-
tion (Fig. 7D). Preconditioning with diazoxide further increased
this ratio directly after hypoxia as well as after re-oxygenation
(Fig. 7D).
A preconditioning effect of diazoxide can be reproduced
in human islets in vitro
Limited access to human islets allowed us to test in a pilot
fashion whether effects observed in rat islets could be reproduced
in human islets. The protocol that we used was identical to the
standard one for rat islets. In both of two preparations of human
islets preconditioning with diazoxide increased the mean insulin
content after hypoxia and re-oxygenation. The mean insulin
content was 746 mU per islet in preconditioned islets as compared
to 447 mU in islets that were not preconditioned.
Preconditioning by diazoxide in vitro enhances IRI
contents in islet transplants and lowers diabetes-induced
hyperglycemia
We tested, as proof of concept, for relevance of preconditioning
in vitro for the outcome of islet transplantation. The concept was
tested in three different ways. In one transplantations were
performed to non-diabetic rats. Islets from rats were cultured for
22 h with or without diazoxide in vitro and then transplanted
under the kidney capsule of syngeneic non-diabetic rats. Five days
after transplantation the grafts were cut out and insulin contents
measured. The insulin contents were increased by 183637% due
to preconditioning (Fig. 8A).
The ability of preconditioning to affect the level of hypergly-
cemia in diabetes was tested in two models of streptozotocin
diabetes. In the first model of diabetes we used streptozotocin
diabetic rats. Injections of 1200–1600 rat islets i.p. without
preconditioning were marginally effective in lowering blood
glucose over a 7 day period (Fig. 8B+C). Preconditioned islets
Table 1. ATP, ADP, protein, total DNA and mitochondrial DNA/nuclear DNA in islets immediately after hypoxia and after re-
oxygenation.
ATP
(pmol/islet)
ADP
(pmol/islet)
protein
(mg/islet)
DNA
(ng/islet)
ATP/DNA
(nmol/mg DNA)
mDNA/nDNA
(ratio)
immediately after hypoxia
normoxia 4.8960.5 0.4260.1 0.2460.01 8.9460.7 6.6160.6
normoxia+preconditioning 4.2160.3 0.5260.1 0.2960.003 8.9261.3 7.1260.7
hypoxia 1.2060.02* 0.0360.004* 0.2060.01* 6.4561.2* 3.2060.1*
hypoxia+preconditioning 1.3160.02* 0.0960.01* 0.2460.01* 6.4861.4* 4.1560.1*
after re-oxygenation
normoxia 4.960.1 0.2560.02 0.2760.01 9.6761.3 6.8560.1 1.0
normoxia+preconditioning 4.9260.5 0.2760.01 0.2760.03 9.5561.7 7.9561.3 0.8760.12
hypoxia 2.560.01* 0.1160.02* 0.1460.01* 5.5461.0* 6.9960.4 0.7060.13*
hypoxia+preconditioning 2.016 0.1* 0.1060.01* 0.1460.01* 5.8661.1* 5.4960.6 0.5260.08*
*P,0.05 vs. no hypoxia, n = 6 except for protein (n = 3) and for mDNA/nDNA (n = 5).
doi:10.1371/journal.pone.0067498.t001
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were significantly more effective in this respect. In the second
model of diabetes we tested for preconditioning effects in human
islets, which were transplanted i.p. to streptozotocin-diabetic nude
mice. (Here we used alginate-encapsulated islets, since encapsu-
lation increases the effectiveness of i.p. transplants, unpublished
observations). There was also in this experimental model a
stronger effect on hyperglycemia over a 14 day period in islets
which had been subjected to preconditioning (Fig. 8D).
Discussion and Conclusions
We demonstrate for the first time a robust preconditioning effect
of diazoxide that partially protects against the negative impact by
hypoxia on viability and insulin biosynthesis. We find that the
beneficial effect is time dependent, associated with reduced Ca2+
inflow and reduction of glucose oxidation and a corrective
influence on proteins of oxidative phosphorylation. We also
provide proof of concept for a beneficial influence by precondi-
tioning on the function of transplanted islets. Further, we extend
previous observations on the general impact of hypoxia on beta
cell function and survival.
We first wish to discuss the impact of hypoxia in general. We
find, as others [1], that insulin secretion is blocked during hypoxia.
Novel findings are that cellular insulin contents and biosynthesis
are afflicted to a larger extent than responses to glucose in terms of
insulin release, oxidation and O2 consumption. Negative effects of
hypoxia on insulin biosynthesis were suggested by the hypoxia-
induced marked decrease in insulin contents, by the profound
decrease in islet proinsulin which was registered immediately after
the hypoxic event, by direct measurements of 3H- leucine
incorporation into proinsulin following re-oxygenation and, lastly,
by the lack of enhancement of insulin degradation. Novel findings
are also the acute and lingering impact by hypoxia on proteins of
mitochondrial complexes as well as lowering of the mtDNA/
nDNA ratio, the latter being in line with functional and/or
structural reductions of beta cell mitochondria. One may speculate
that such reductions could be more crucial for upholding
biosynthesis than for secretory processes.
Figure 7. Influence on preconditioning by conditions affecting inflow of Ca2+ and/or insulin secretion (A–B), HIF1a (C) and AMPK
(D). In A and B preconditioning was performed with diazoxide (dz) in the presence or absence of tolbutamide (100 mmol/l) or potassium (30 mmol/l).
Also tested were effects of nifedipine (10 mmol/l) and cooling (28uC). A depicts insulin secreted to the culture medium expressed as % of no addition.
B depicts islet insulin contents measured after 5.5 h of hypoxia followed by re-oxygenation. Incremental effects are shown as % of hypoxia only.
Absolute values for Fig. 7A and B are shown in Text S1. Mean 6 SEM of four experiments. C depicts effects of preconditioning with diazoxide (dz) on
HIF1a protein (Western blot) before hypoxia and after 5.5 h of normoxia/hypoxia. Mean 6 SEM of nine experiments, *P,0.05 vs. no previous
diazoxide. D depicts effects of preconditioning with diazoxide (dz) by Western blotting on the ratio of AMPKa to phosphorylated AMPKa (p-AMPKa)
in sequence to hypoxia and after re-oxygenation. Mean 6 SEM of three experiments, *P,0.05 vs. no previous diazoxide. Representative blots are
shown. Red columns: normoxia; blue columns: hypoxia.
doi:10.1371/journal.pone.0067498.g007
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We next discuss the effects termed here preconditioning. A
question to be answered before further discussion is what
preconditioning stands for and whether agents and in particular
diazoxide are retained after the pre-culture period, in which case
one would observe a combined effect of the previous and a still
present exposure to the agent. Our unpublished observations do
not indicate a lingering presence of diazoxide, since the inhibitory
effects on insulin secretion of a previous 22 h exposure to
diazoxide are reversed within one hour. However, effects of
putatively retained diazoxide which are not related to effects of K+
ATP channels cannot be completely excluded. It is with this
reservation that we are using the term preconditioning throughout
the study.
We note that the beneficial effects of previous diazoxide
encompassed both function (insulin biosynthesis) and viability
(necrosis). However, the concomitantly registered increase in
apoptosis demonstrates that preconditioning with diazoxide was
not able to wholly counteract on-going hypoxia-induced cellular
damage.
As to mechanisms of preconditioning our results give evidence
that preconditioning depends, at least in part, on inhibition of
stimulated Ca2+ inflow. Thus, preconditioning was totally abol-
ished not only when the diazoxide effect on K+-ATP channels was
opposed by a sulphonylurea drug, but also by the co-presence of
elevated potassium which induces inflow of Ca2+ without involving
K+-ATP channels. Furthermore, nifedipine, which blocks Ca2+
inflow by a direct effect on L-type voltage-dependent calcium
channels, reproduced to a large extent the beneficial effect of
diazoxide on cellular insulin contents. Both diazoxide [24] and
nifedipine [25] are known to lower cytosolic calcium in islets in the
present dose and time (22 h) perspective. (Perhaps due to the
somewhat weaker effects of nifedipine seen in vitro we were not
able to obtain a significant beneficial effect in a transplantation
protocol, results not shown). In this context it is interesting to note
that another calcium blocker, verapamil, when administered in
vivo reduced beta cell apoptosis and enhanced endogenous insulin
levels [26].
The cooling experiments were designed to dissociate, at least
partly, the effect of inhibition of Ca2+ inflow from inhibition of
exocytosis. Lowering temperature into the range that we employed
is bound to affect exocytosis to a much greater extent than Ca2+
inflow [20,21,22]. The 64% inhibition of insulin secretion by
cooling that we observe did not protect against the hypoxia-
induced lowering of insulin contents. This finding we interpret to
rule out a major protective influence by inhibition of insulin
secretion per se. In this context it is notable that a protective effect
Figure 8. Effects in vivo by preconditioning in vitro. A shows effect of preconditioning with diazoxide on insulin content of islets (mU/islet)
transplanted under the kidney capsule to non-diabetic rats. Transplants were taken out after five days. *P,0.05 vs. no previous diazoxide, mean 6
SEM of six experiments. B: Effect of preconditioning with diazoxide on B-glucose levels in streptozotocin-diabetic rats transplanted i.p. with 1200–
1600 islets. Mean 6 SEM of four experiments. In C the AUC (area under the curve) calculated from B is shown. *P,0.05 vs. no transplantation and
{P,0.05 vs. no previous diazoxide. Red squares: no transplantation; blue circles: transplantation but no previous diazoxide; green triangles:
transplantation with islets pre-treated with diazoxide. D: Effect of preconditioning with diazoxide on B-glucose levels for 14 days (mean 6 SEM) in
streptozotocin-diabetic NMRI nu/nu mice transplanted i.p. with 600 encapsulated human islet equivalents. Mean6 SEM of five experiments. *P,0.05
vs. before transplantation and {P,0.05 vs. no previous diazoxide. Red columns: before transplantation; blue columns: transplantation but no
previous diazoxide; green columns: transplantation with islets pre-treated with diazoxide.
doi:10.1371/journal.pone.0067498.g008
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of an analogue of diazoxide against streptozotocin toxicity also
occurred independently of effects on insulin secretion [27].
A toxic effect of a sustained elevation of cytosolic calcium is well
established in other tissues and may be mediated by several
mechanisms, some of which include the production of ROS [28].
In this context it is interesting that hypoxia in beta cells acutely
increases intracellular calcium [29].
Notwithstanding the evidence for a role of calcium behind the
preconditioning effects one should not dismiss the possibility of
additional factors of importance. A direct effect of diazoxide on
mitochondria (not tied to putative K+ ATP channels in
mitochondria) has been demonstrated [30] and may be tied to
the modest but significant lowering effects on mitochondrial
metabolism that we observe. (The lack of correspondence between
effects by diazoxide on oxidation and on ATP and ADP levels
could possibly be explained by a decrease in energy expenditure).
Reduced metabolism could in turn be related to enhancement of
HIF-1 alpha and phosphorylated AMPK, which are recognized to
be the two major hypoxia-sensing factors of cells [6]. As described
in Results the effects of diazoxide on the HIF-1 alpha protein were
complex, however the end results was an enhancing effect after
hypoxia. It seems possible that an accelerated rise in HIF-1 alpha
during hypoxia could lessen damage afflicted by hypoxia. Such
notion is in line with the observation that forced over-expression of
HIF-1 alpha improved the results of beta cell transplantation
[31,32]. As to effects on AMPK this parameter which is sensitive
to changes in metabolism was enhanced by diazoxide in response
to hypoxia, i.e. the ratio of phosphorylated to non-phosphorylated
protein increased beyond the effects of hypoxia per se. In this
context it is interesting to note that AMPK activation has been
linked to protective effects of ischemic preconditioning [33] and
could be another factor of importance for preconditioning by
diazoxide.
Are the present results clinically relevant? The robustness of the
diazoxide effect, and the beneficial effects of preconditioning seen
post transplantation for both rat and human islets are all
supportive. One may question the likelihood for merely a short
term treatment in vitro to improve transplantation results long
term.? However, the early time period after transplantation is
known to determine the fate of transplanted islets to a large part.
Several negative factors are then transiently operative and
combine to eliminate the majority of islets [34]. Reducing the
impact of one of these negative factors, i.e. hypoxia, could help
more beta cells survive the initial and critical period after
transplantation thereby increasing the potential for better trans-
plant functioning in the long term. In any case, our data should
give impetus for further studies in which the usefulness of
preconditioning in vitro for the outcome of clinical transplanta-
tions in vivo can be extensively tested.
Supporting Information
Figure S1 Effect of preconditioning with diazoxide measured
after reoxygenation on A: islet proinsulin content. *P,0.05 vs.
normoxia, {P,0.05 vs. before re-oxygenation. B: proinsulin
expressed as % of total IRI. *P,0.05 vs. no preconditioning with
diazoxide. Mean 6 SEM of five experiments.
(TIF)
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